低剂量儿童全身18F-FDG PET/CT的图像质量与病灶检出
回顾性纳入33例儿童肿瘤患者,在全身PET/CT上模拟降低给药剂量至0.12–1.85 MBq/kg,评估图像质量与病灶检出。结果显示主观图像质量和病灶清晰度可维持至1/30剂量(0.12 MBq/kg),1/15剂量下全部高摄取微病灶可定位,1/30剂量下97%可定位;作者认为1/10剂量(0.37 MBq/kg)可达最佳图像质量。
要点
- 主观图像质量和病灶清晰度可维持至1/30剂量(0.12 MBq/kg)。
- 1/15剂量下全部18F-FDG高摄取微病灶可定位,1/30剂量下97%可定位。
- 1/10剂量(0.37 MBq/kg)可达最佳图像质量。
核心结论
- 全身PET/CT在维持儿童患者图像质量和微病灶诊断性能的前提下可显著降低给药剂量。
- 数据提示使用全身PET/CT时,给药剂量降至1/10剂量(0.37 MBq/kg)可达最佳图像质量。
研究设计与样本
- 回顾性纳入33例儿童肿瘤患者(体重8.5–58.5 kg,年龄0.8–17.6岁)。
- 使用uEXPLORER全身PET/CT,18F-FDG给药剂量3.7 MBq/kg,采集时间600 s。
- 通过截断列表模式PET数据降低计数密度,模拟低剂量图像(0.12–1.85 MBq/kg)。
- 主观图像质量采用5分制评分,半定量指标基于健康肝脏和疑似病灶的ROI分析与全剂量图像比较。
主要发现
- 主观图像质量和病灶清晰度可维持至1/30剂量(0.12 MBq/kg);1/2和1/10剂量组获得良好图像质量评分。
- 1/30至1/10剂量组图像噪声的恶化程度显著大于整体质量和病灶清晰度(均p < 0.05)。
- 随剂量降低,肝脏SUVmax和SD逐渐升高(p < 0.05),但病灶SUVmax和病灶-本底比(LBR)降至1/30剂量仍无显著偏差。
关键数值与推荐
- 主观图像质量采用5分制评分。
- 1/30至1/10剂量组图像噪声与整体质量及病灶清晰度比较均p < 0.05。
- 肝脏SUVmax和SD随剂量降低逐渐升高(p < 0.05)。
临床怎么用
- 儿童肿瘤全身18F-FDG PET/CT可考虑将给药剂量降至1/10剂量(0.37 MBq/kg)以维持最佳图像质量。
- 在需要进一步降低剂量时,1/30剂量(0.12 MBq/kg)仍可维持主观图像质量和病灶清晰度,但图像噪声增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the effects of dose reduction on image quality and lesion detectability of oncological 18F-FDG total-body PET/CT in pediatric oncological patients and explore the minimum threshold of administered tracer activity. METHODS: A total of 33 pediatric patients (weight 8.5-58.5 kg; age 0.8-17.6 years) underwent total-body PET/CT using uEXPLORER scanner with an 18F-FDG administered dose of 3.7 MBq/kg and an acquisition time of 600 s were retrospectively enrolled. Low-dose images (0.12-1.85 MBq/kg) were simulated by truncating the list-mode PET data to reducing count density. Subjective image quality was rated on a 5-point scale. Semi-quantitative uptake metrics for low-dose images were assessed using region-of-interest (ROI) analysis of healthy liver and suspected lesions and were compared with full-dose images. The micro-lesion detectability was compared among the dose-dependent PET images. RESULTS: Our analysis shows that sufficient subjective image quality and lesion conspicuity could be maintained down to 1/30th (0.12 MBq/kg) of the administered dose of 18F-FDG, where good image quality scores were given to 1/2- and 1/10- dose groups. The image noise was significantly more deranged than the overall quality and lesion conspicuity in 1/30- to 1/10-dose groups (all p < 0.05). With reduced doses, quantitative analysis of ROIs showed that SUVmax and SD in the liver increased gradually (p < 0.05), but SUVmax in the lesions and lesion-to-background ratio (LBR) showed no significant deviation down to 1/30-dose. One hundred percent of the 18F-FDG-avid micro-lesions identified in full-dose images were localized down to 1/15-dose images, while 97% of the lesion were localized in 1/30-dose images. CONCLUSION: The total-body PET/CT might significantly decrease the administered dose upon maintaining the image quality and diagnostic performance of micro-lesions in pediatric patients. Data suggests that using total-body PET/CT, optimal image quality could be achieved with an administered dose-reduction down to 1/10-dose (0.37 MBq/kg).
引用
- Zhao YM, Li YH, Chen T, et al. Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT. Eur J Nucl Med Mol Imaging. 2021. PMID: 33738519. doi:10.1007/s00259-021-05304-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。